Skin cancer in asians: part 1: nonmelanoma skin cancer

Since the 1960s, basal cell carcinoma and squamous cell carcinoma among the Caucasian population have increased 3 to 8 percent annually. Although Asians display relative protection from basal cell carcinoma and squamous cell carcinoma, incidence rates of these nonmelanoma skin cancers have been incr...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of clinical and aesthetic dermatology Vol. 2; no. 8; pp. 39 - 42
Main Authors Kim, Grace K, Del Rosso, James Q, Bellew, Susun
Format Journal Article
LanguageEnglish
Published United States Matrix Medical Communications 01.08.2009
Subjects
Literature Review
Online AccessGet full text

Cover

More Information
Summary:Since the 1960s, basal cell carcinoma and squamous cell carcinoma among the Caucasian population have increased 3 to 8 percent annually. Although Asians display relative protection from basal cell carcinoma and squamous cell carcinoma, incidence rates of these nonmelanoma skin cancers have been increasing over the past three decades. With changing demographics and a steady rise in the minority population in the United States, there is an increased need for further studies of cutaneous malignancies within Asian and other ethnic populations. This article reviews nonmelanoma skin cancers in the Asian population with an insight into contributing factors, such as skin type, occupation, cultural practices, and genetic components.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
DISCLOSURE: Drs. Kim and Bellew report no relevant conflicts of interest. Dr. Del Rosso is a consultant, speaker, and/or researcher for Allergan, Coria, Galderma, Graceway, Intendis, Medicis, Onset Therapeutics, Obagi Medical Products, Ortho Dermatology, PharmaDerm, Quinnova, Ranbaxy, SkinMedica, Stiefel, Triax, Unilever, and Warner-Chilcott.
ISSN:1941-2789
2689-9175